Venacavoscopy assisted inferior Vena cava thrombus resection for T3b/c renal cell carcinoma

Resection of intrahepatic and suprahepatic inferior vena cava (IVC) thrombi associated with renal cell carcinoma (RCC) can be surgically demanding procedures that can involve multidisciplinary surgical teams.

One aspect of the procedure that is approached with trepidation is the actual removal of the vena cava tumor thrombus, which is often done as a "blind" element of the operation. Here, Lowentritt and colleagues describe a very useful surgical adjunct to vena cava thrombectomy, using a flexible cystoscope to perform venacavoscopy, to assist in ensuring complete tumor removal.

The authors report on the use of a 16fr flexible cystoscope to perform intraoperative venacavoscopy during IVC thrombus removal for intrahepatic and suprahepatic RCC thrombi in seven patients. The procedure added on average 5.6 minutes to the operative procedure. Residual tumor in the IVC was identified in 3/7 patients, which was subsequently removed through a combination of endoscopic and manual manipulation. None of the residual tumor thrombi that were identified with this technique were noted using intraoperative transesophageal echocardiography. Average blood loss for the patients in the study was 1.170 liters, which was not added to significantly by the addition of venacavoscopy. With a mean follow-up of 17.6 months, 5/7 patients are still alive after surgery.

In describing their surgical technique, the authors describe extracting the thrombus with the use of a distended foley balloon, much like a vascular Fogarty catheter. They then use Rommel tourniquets to occlude and isolate specific segments of the IVC, which allow venacavoscopy with the use of infused normal saline, without significant blood loss. Using this technique, the IVC, as well as the hepatic veins and right atrium can be inspected for evidence of retained thrombus after thrombectomy.

This represents a very innovative surgical "trick" that may greatly assist in assuring completeness of IVC thrombectomy for T3b/c RCC.

J Urol 176: 468-471, 2006

Written by Christopher G. Wood, MD - UroToday


http://www.UroToday.comThis article is republished with kind permission from our friends at UroToday. UroToday's vision is to create a quality, global online publication providing accurate and timely education that is clinically relevant in the practice of Urology. Copyright 2006 UroToday. All rights reserved.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Mapping human biology: Human Cell Atlas leads a new era in precision medicine